Partial-onset Seizures

• FDA label_change · 2025-12-29
  FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)

  FDA approved a supplemental application for Pregabalin submitted by Cipla USA, Inc., indicating changes to the drug's labeling. The notice d…

• FDA label_change · 2022-08-04
  FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)

  The FDA issued a supplemental approval for oxcarbazepine by Advagen Pharma Limited, resulting in changes to the product's labeling.

• FDA label_change · 2022-05-25
  FDA Approved: ZONISAMIDE — Supplemental Application (Viona Pharmaceuticals Inc)

  The FDA approved a supplemental application for Zonisamide from Viona Pharmaceuticals Inc, resulting in changes to the product label.

• FDA label_change · 2021-09-20
  FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)

  FDA approved a supplemental application for VIMPAT (lacosamide) filed by UCB, Inc. The approval results in a labeling change to the product …

• FDA label_change · 2016-04-06
  FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

  FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2016-04-06
  FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)

  The FDA approved a supplemental application for Keppra XR (levetiracetam) from UCB, Inc., resulting in changes to the product labeling. The …